![Benefit of treatment of latent tuberculosis infection in individual patients | European Respiratory Society Benefit of treatment of latent tuberculosis infection in individual patients | European Respiratory Society](https://erj.ersjournals.com/content/erj/early/2015/09/24/13993003.00577-2015/F1.large.jpg)
Benefit of treatment of latent tuberculosis infection in individual patients | European Respiratory Society
![Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials - The Lancet Infectious Diseases Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/31b197b6-8380-49e5-b769-8554ad5d9ada/gr1.gif)
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials - The Lancet Infectious Diseases
![Factors associated with non-initiation of latent tuberculosis treatment among healthcare workers with a positive interferon-gamma releasing assay | Scientific Reports Factors associated with non-initiation of latent tuberculosis treatment among healthcare workers with a positive interferon-gamma releasing assay | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-37319-7/MediaObjects/41598_2018_37319_Fig1_HTML.png)
Factors associated with non-initiation of latent tuberculosis treatment among healthcare workers with a positive interferon-gamma releasing assay | Scientific Reports
![National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area | European Respiratory Society National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area | European Respiratory Society](https://erj.ersjournals.com/content/erj/51/1/1701226/F1.large.jpg)
National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area | European Respiratory Society
![Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries | European Respiratory Society Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries | European Respiratory Society](https://erj.ersjournals.com/content/erj/46/6/1563/F1.large.jpg)
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries | European Respiratory Society
![BCG vaccination following latent TB treatment: Possible implications for different settings - International Journal of Infectious Diseases BCG vaccination following latent TB treatment: Possible implications for different settings - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/21f2b851-71e2-4f1a-8fc3-5f785b130145/gr1_lrg.jpg)
BCG vaccination following latent TB treatment: Possible implications for different settings - International Journal of Infectious Diseases
![Latent tuberculosis infection screening and treatment in congregate settings (TB FREE COREA): protocol for a prospective observational study in Korea | BMJ Open Latent tuberculosis infection screening and treatment in congregate settings (TB FREE COREA): protocol for a prospective observational study in Korea | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/10/2/e034098/F1.large.jpg)